Senior insider sale
QUINCE THERAPEUTICS, INC. — senior position signals high conviction
$173.2K
50K shares
What this filing means
BENATTI LUCA plans to sell 50K shares of QUINCE THERAPEUTICS, INC. valued at approximately $173.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/29/2025ACC: 0001628280-25-059050
50K
Shares to sell
$173.2K
Approx. market value
39.18K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU
CASH
12/3/2025
39.18KTotal acquired39.18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/3/2025 | RSU CASH | 39.18K | — |
| Total | 39.18K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
50K
Market value
$173.2K
12/26/2025
Total
Units
50K
Value
$173.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/26/2025 | 50K | $173.2K | NASDAQ | Planned |
| Total | 50K | $173.2K | ||